nodes	percent_of_prediction	percent_of_DWPC	metapath
Dinoprost Tromethamine—SLC22A11—Pravastatin—atherosclerosis	0.201	0.34	CbGbCtD
Dinoprost Tromethamine—SLC22A7—Pravastatin—atherosclerosis	0.191	0.324	CbGbCtD
Dinoprost Tromethamine—SLC22A8—Pravastatin—atherosclerosis	0.117	0.198	CbGbCtD
Dinoprost Tromethamine—SLC22A6—Pravastatin—atherosclerosis	0.0814	0.138	CbGbCtD
Dinoprost Tromethamine—TBXA2R—artery—atherosclerosis	0.00979	0.124	CbGeAlD
Dinoprost Tromethamine—TBXA2R—endothelium—atherosclerosis	0.00827	0.105	CbGeAlD
Dinoprost Tromethamine—TBXA2R—blood vessel—atherosclerosis	0.00763	0.097	CbGeAlD
Dinoprost Tromethamine—PTGIR—artery—atherosclerosis	0.00531	0.0675	CbGeAlD
Dinoprost Tromethamine—PTGIR—endothelium—atherosclerosis	0.00449	0.057	CbGeAlD
Dinoprost Tromethamine—PTGIR—blood vessel—atherosclerosis	0.00414	0.0526	CbGeAlD
Dinoprost Tromethamine—Pregnancy—Lovastatin—atherosclerosis	0.00359	0.0288	CcSEcCtD
Dinoprost Tromethamine—Hepatic necrosis—Lovastatin—atherosclerosis	0.0035	0.0281	CcSEcCtD
Dinoprost Tromethamine—TBXA2R—cardiovascular system—atherosclerosis	0.0034	0.0433	CbGeAlD
Dinoprost Tromethamine—Pregnancy—Simvastatin—atherosclerosis	0.00335	0.0269	CcSEcCtD
Dinoprost Tromethamine—Hepatic necrosis—Simvastatin—atherosclerosis	0.00328	0.0263	CcSEcCtD
Dinoprost Tromethamine—PTGER3—connective tissue—atherosclerosis	0.00301	0.0383	CbGeAlD
Dinoprost Tromethamine—TBXA2R—adipose tissue—atherosclerosis	0.003	0.0381	CbGeAlD
Dinoprost Tromethamine—Hepatic necrosis—Pravastatin—atherosclerosis	0.00296	0.0238	CcSEcCtD
Dinoprost Tromethamine—HPGDS—connective tissue—atherosclerosis	0.0026	0.0331	CbGeAlD
Dinoprost Tromethamine—Hyperventilation—Niacin—atherosclerosis	0.00254	0.0204	CcSEcCtD
Dinoprost Tromethamine—Burning sensation—Niacin—atherosclerosis	0.00252	0.0202	CcSEcCtD
Dinoprost Tromethamine—PTGER3—adipose tissue—atherosclerosis	0.00231	0.0294	CbGeAlD
Dinoprost Tromethamine—HPGDS—cardiovascular system—atherosclerosis	0.00226	0.0288	CbGeAlD
Dinoprost Tromethamine—PTGIR—connective tissue—atherosclerosis	0.00212	0.027	CbGeAlD
Dinoprost Tromethamine—Hypertonia—Rosuvastatin—atherosclerosis	0.00211	0.0169	CcSEcCtD
Dinoprost Tromethamine—TBXA2R—liver—atherosclerosis	0.0021	0.0268	CbGeAlD
Dinoprost Tromethamine—Diabetes mellitus—Rosuvastatin—atherosclerosis	0.002	0.0161	CcSEcCtD
Dinoprost Tromethamine—HPGDS—adipose tissue—atherosclerosis	0.002	0.0254	CbGeAlD
Dinoprost Tromethamine—PTGFR—adipose tissue—atherosclerosis	0.00185	0.0235	CbGeAlD
Dinoprost Tromethamine—PTGIR—cardiovascular system—atherosclerosis	0.00185	0.0235	CbGeAlD
Dinoprost Tromethamine—PTGIR—adipose tissue—atherosclerosis	0.00163	0.0207	CbGeAlD
Dinoprost Tromethamine—Diabetes mellitus—Simvastatin—atherosclerosis	0.00159	0.0127	CcSEcCtD
Dinoprost Tromethamine—Hypertonia—Niacin—atherosclerosis	0.00153	0.0123	CcSEcCtD
Dinoprost Tromethamine—Diabetes mellitus—Niacin—atherosclerosis	0.00146	0.0117	CcSEcCtD
Dinoprost Tromethamine—SLCO3A1—adipose tissue—atherosclerosis	0.00144	0.0183	CbGeAlD
Dinoprost Tromethamine—SLCO2A1—adipose tissue—atherosclerosis	0.00142	0.0181	CbGeAlD
Dinoprost Tromethamine—HPGDS—liver—atherosclerosis	0.0014	0.0178	CbGeAlD
Dinoprost Tromethamine—Urinary tract infection—Rosuvastatin—atherosclerosis	0.00131	0.0105	CcSEcCtD
Dinoprost Tromethamine—PTGFR—liver—atherosclerosis	0.00129	0.0165	CbGeAlD
Dinoprost Tromethamine—Haematuria—Rosuvastatin—atherosclerosis	0.00128	0.0103	CcSEcCtD
Dinoprost Tromethamine—Diplopia—Pravastatin—atherosclerosis	0.00125	0.01	CcSEcCtD
Dinoprost Tromethamine—PTGIR—liver—atherosclerosis	0.00114	0.0145	CbGeAlD
Dinoprost Tromethamine—SLC22A11—liver—atherosclerosis	0.00111	0.0141	CbGeAlD
Dinoprost Tromethamine—Urinary tract infection—Lovastatin—atherosclerosis	0.00111	0.00888	CcSEcCtD
Dinoprost Tromethamine—SLC22A7—liver—atherosclerosis	0.00109	0.0138	CbGeAlD
Dinoprost Tromethamine—Dysuria—Pravastatin—atherosclerosis	0.00101	0.0081	CcSEcCtD
Dinoprost Tromethamine—SLCO3A1—liver—atherosclerosis	0.00101	0.0128	CbGeAlD
Dinoprost Tromethamine—SLCO2A1—liver—atherosclerosis	0.000997	0.0127	CbGeAlD
Dinoprost Tromethamine—Sweating—Niacin—atherosclerosis	0.000937	0.00752	CcSEcCtD
Dinoprost Tromethamine—Urinary tract infection—Pravastatin—atherosclerosis	0.000936	0.00751	CcSEcCtD
Dinoprost Tromethamine—Chills—Lovastatin—atherosclerosis	0.000917	0.00736	CcSEcCtD
Dinoprost Tromethamine—Cough—Rosuvastatin—atherosclerosis	0.000916	0.00735	CcSEcCtD
Dinoprost Tromethamine—Angiopathy—Ezetimibe—atherosclerosis	0.00091	0.0073	CcSEcCtD
Dinoprost Tromethamine—Immune system disorder—Ezetimibe—atherosclerosis	0.000906	0.00726	CcSEcCtD
Dinoprost Tromethamine—Back pain—Lovastatin—atherosclerosis	0.000861	0.0069	CcSEcCtD
Dinoprost Tromethamine—Chills—Simvastatin—atherosclerosis	0.000858	0.00688	CcSEcCtD
Dinoprost Tromethamine—Muscle spasms—Lovastatin—atherosclerosis	0.000855	0.00686	CcSEcCtD
Dinoprost Tromethamine—Infection—Rosuvastatin—atherosclerosis	0.000851	0.00683	CcSEcCtD
Dinoprost Tromethamine—Back pain—Ezetimibe—atherosclerosis	0.000844	0.00677	CcSEcCtD
Dinoprost Tromethamine—Muscle spasms—Ezetimibe—atherosclerosis	0.000839	0.00673	CcSEcCtD
Dinoprost Tromethamine—Ill-defined disorder—Lovastatin—atherosclerosis	0.000826	0.00662	CcSEcCtD
Dinoprost Tromethamine—Ill-defined disorder—Ezetimibe—atherosclerosis	0.00081	0.0065	CcSEcCtD
Dinoprost Tromethamine—Malaise—Lovastatin—atherosclerosis	0.000802	0.00644	CcSEcCtD
Dinoprost Tromethamine—Muscle spasms—Simvastatin—atherosclerosis	0.0008	0.00642	CcSEcCtD
Dinoprost Tromethamine—Angiopathy—Niacin—atherosclerosis	0.000796	0.00639	CcSEcCtD
Dinoprost Tromethamine—Chills—Niacin—atherosclerosis	0.000788	0.00632	CcSEcCtD
Dinoprost Tromethamine—Malaise—Ezetimibe—atherosclerosis	0.000787	0.00631	CcSEcCtD
Dinoprost Tromethamine—Chills—Pravastatin—atherosclerosis	0.000776	0.00622	CcSEcCtD
Dinoprost Tromethamine—Ill-defined disorder—Simvastatin—atherosclerosis	0.000772	0.00619	CcSEcCtD
Dinoprost Tromethamine—Paraesthesia—Rosuvastatin—atherosclerosis	0.000769	0.00617	CcSEcCtD
Dinoprost Tromethamine—Cough—Ezetimibe—atherosclerosis	0.000762	0.00611	CcSEcCtD
Dinoprost Tromethamine—Chest pain—Lovastatin—atherosclerosis	0.000758	0.00608	CcSEcCtD
Dinoprost Tromethamine—Hypertension—Ezetimibe—atherosclerosis	0.000753	0.00604	CcSEcCtD
Dinoprost Tromethamine—Malaise—Simvastatin—atherosclerosis	0.000751	0.00602	CcSEcCtD
Dinoprost Tromethamine—Discomfort—Lovastatin—atherosclerosis	0.000748	0.006	CcSEcCtD
Dinoprost Tromethamine—Chest pain—Ezetimibe—atherosclerosis	0.000743	0.00596	CcSEcCtD
Dinoprost Tromethamine—Muscle spasms—Niacin—atherosclerosis	0.000735	0.00589	CcSEcCtD
Dinoprost Tromethamine—Discomfort—Ezetimibe—atherosclerosis	0.000734	0.00589	CcSEcCtD
Dinoprost Tromethamine—Pain—Rosuvastatin—atherosclerosis	0.000733	0.00588	CcSEcCtD
Dinoprost Tromethamine—Muscle spasms—Pravastatin—atherosclerosis	0.000723	0.0058	CcSEcCtD
Dinoprost Tromethamine—Infection—Lovastatin—atherosclerosis	0.000721	0.00579	CcSEcCtD
Dinoprost Tromethamine—Chest pain—Simvastatin—atherosclerosis	0.000709	0.00568	CcSEcCtD
Dinoprost Tromethamine—Infection—Ezetimibe—atherosclerosis	0.000708	0.00568	CcSEcCtD
Dinoprost Tromethamine—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000706	0.00566	CcSEcCtD
Dinoprost Tromethamine—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000701	0.00562	CcSEcCtD
Dinoprost Tromethamine—Discomfort—Simvastatin—atherosclerosis	0.0007	0.00562	CcSEcCtD
Dinoprost Tromethamine—Ill-defined disorder—Pravastatin—atherosclerosis	0.000698	0.0056	CcSEcCtD
Dinoprost Tromethamine—Syncope—Niacin—atherosclerosis	0.000685	0.0055	CcSEcCtD
Dinoprost Tromethamine—Malaise—Pravastatin—atherosclerosis	0.000679	0.00544	CcSEcCtD
Dinoprost Tromethamine—Abdominal pain—Rosuvastatin—atherosclerosis	0.000677	0.00543	CcSEcCtD
Dinoprost Tromethamine—Infection—Simvastatin—atherosclerosis	0.000675	0.00541	CcSEcCtD
Dinoprost Tromethamine—Loss of consciousness—Niacin—atherosclerosis	0.000672	0.00539	CcSEcCtD
Dinoprost Tromethamine—Cough—Niacin—atherosclerosis	0.000667	0.00535	CcSEcCtD
Dinoprost Tromethamine—Cough—Pravastatin—atherosclerosis	0.000657	0.00527	CcSEcCtD
Dinoprost Tromethamine—Paraesthesia—Lovastatin—atherosclerosis	0.000652	0.00523	CcSEcCtD
Dinoprost Tromethamine—Hypertension—Pravastatin—atherosclerosis	0.00065	0.00521	CcSEcCtD
Dinoprost Tromethamine—Dyspnoea—Lovastatin—atherosclerosis	0.000647	0.00519	CcSEcCtD
Dinoprost Tromethamine—Chest pain—Pravastatin—atherosclerosis	0.000641	0.00514	CcSEcCtD
Dinoprost Tromethamine—Paraesthesia—Ezetimibe—atherosclerosis	0.00064	0.00513	CcSEcCtD
Dinoprost Tromethamine—Dyspnoea—Ezetimibe—atherosclerosis	0.000635	0.00509	CcSEcCtD
Dinoprost Tromethamine—Discomfort—Pravastatin—atherosclerosis	0.000633	0.00508	CcSEcCtD
Dinoprost Tromethamine—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000631	0.00506	CcSEcCtD
Dinoprost Tromethamine—Pain—Lovastatin—atherosclerosis	0.000621	0.00498	CcSEcCtD
Dinoprost Tromethamine—Asthenia—Rosuvastatin—atherosclerosis	0.000615	0.00493	CcSEcCtD
Dinoprost Tromethamine—Shock—Niacin—atherosclerosis	0.000614	0.00492	CcSEcCtD
Dinoprost Tromethamine—Infection—Pravastatin—atherosclerosis	0.00061	0.00489	CcSEcCtD
Dinoprost Tromethamine—Paraesthesia—Simvastatin—atherosclerosis	0.00061	0.00489	CcSEcCtD
Dinoprost Tromethamine—Pain—Ezetimibe—atherosclerosis	0.000609	0.00489	CcSEcCtD
Dinoprost Tromethamine—Tachycardia—Niacin—atherosclerosis	0.000609	0.00488	CcSEcCtD
Dinoprost Tromethamine—Pruritus—Rosuvastatin—atherosclerosis	0.000606	0.00486	CcSEcCtD
Dinoprost Tromethamine—Dyspnoea—Simvastatin—atherosclerosis	0.000606	0.00486	CcSEcCtD
Dinoprost Tromethamine—Hyperhidrosis—Niacin—atherosclerosis	0.000603	0.00484	CcSEcCtD
Dinoprost Tromethamine—Feeling abnormal—Lovastatin—atherosclerosis	0.000598	0.0048	CcSEcCtD
Dinoprost Tromethamine—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000594	0.00476	CcSEcCtD
Dinoprost Tromethamine—Hyperhidrosis—Pravastatin—atherosclerosis	0.000594	0.00476	CcSEcCtD
Dinoprost Tromethamine—Feeling abnormal—Ezetimibe—atherosclerosis	0.000587	0.00471	CcSEcCtD
Dinoprost Tromethamine—Diarrhoea—Rosuvastatin—atherosclerosis	0.000586	0.0047	CcSEcCtD
Dinoprost Tromethamine—Hypotension—Niacin—atherosclerosis	0.000583	0.00468	CcSEcCtD
Dinoprost Tromethamine—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000582	0.00467	CcSEcCtD
Dinoprost Tromethamine—Pain—Simvastatin—atherosclerosis	0.000581	0.00466	CcSEcCtD
Dinoprost Tromethamine—Abdominal pain—Lovastatin—atherosclerosis	0.000574	0.00461	CcSEcCtD
Dinoprost Tromethamine—Body temperature increased—Lovastatin—atherosclerosis	0.000574	0.00461	CcSEcCtD
Dinoprost Tromethamine—Dizziness—Rosuvastatin—atherosclerosis	0.000567	0.00455	CcSEcCtD
Dinoprost Tromethamine—Body temperature increased—Ezetimibe—atherosclerosis	0.000563	0.00452	CcSEcCtD
Dinoprost Tromethamine—Abdominal pain—Ezetimibe—atherosclerosis	0.000563	0.00452	CcSEcCtD
Dinoprost Tromethamine—Paraesthesia—Niacin—atherosclerosis	0.00056	0.00449	CcSEcCtD
Dinoprost Tromethamine—Feeling abnormal—Simvastatin—atherosclerosis	0.00056	0.00449	CcSEcCtD
Dinoprost Tromethamine—Dyspnoea—Niacin—atherosclerosis	0.000556	0.00446	CcSEcCtD
Dinoprost Tromethamine—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000555	0.00446	CcSEcCtD
Dinoprost Tromethamine—Somnolence—Niacin—atherosclerosis	0.000554	0.00445	CcSEcCtD
Dinoprost Tromethamine—Paraesthesia—Pravastatin—atherosclerosis	0.000551	0.00442	CcSEcCtD
Dinoprost Tromethamine—Dyspnoea—Pravastatin—atherosclerosis	0.000547	0.00439	CcSEcCtD
Dinoprost Tromethamine—Rash—Rosuvastatin—atherosclerosis	0.00054	0.00433	CcSEcCtD
Dinoprost Tromethamine—Dermatitis—Rosuvastatin—atherosclerosis	0.00054	0.00433	CcSEcCtD
Dinoprost Tromethamine—Body temperature increased—Simvastatin—atherosclerosis	0.000537	0.00431	CcSEcCtD
Dinoprost Tromethamine—Abdominal pain—Simvastatin—atherosclerosis	0.000537	0.00431	CcSEcCtD
Dinoprost Tromethamine—Headache—Rosuvastatin—atherosclerosis	0.000537	0.00431	CcSEcCtD
Dinoprost Tromethamine—Hypersensitivity—Lovastatin—atherosclerosis	0.000535	0.00429	CcSEcCtD
Dinoprost Tromethamine—Pain—Niacin—atherosclerosis	0.000533	0.00428	CcSEcCtD
Dinoprost Tromethamine—Pain—Pravastatin—atherosclerosis	0.000525	0.00421	CcSEcCtD
Dinoprost Tromethamine—Hypersensitivity—Ezetimibe—atherosclerosis	0.000525	0.00421	CcSEcCtD
Dinoprost Tromethamine—Asthenia—Lovastatin—atherosclerosis	0.000521	0.00418	CcSEcCtD
Dinoprost Tromethamine—Pruritus—Lovastatin—atherosclerosis	0.000514	0.00412	CcSEcCtD
Dinoprost Tromethamine—Asthenia—Ezetimibe—atherosclerosis	0.000511	0.0041	CcSEcCtD
Dinoprost Tromethamine—Gastrointestinal pain—Niacin—atherosclerosis	0.00051	0.00409	CcSEcCtD
Dinoprost Tromethamine—Nausea—Rosuvastatin—atherosclerosis	0.000509	0.00408	CcSEcCtD
Dinoprost Tromethamine—Feeling abnormal—Pravastatin—atherosclerosis	0.000506	0.00406	CcSEcCtD
Dinoprost Tromethamine—Pruritus—Ezetimibe—atherosclerosis	0.000504	0.00404	CcSEcCtD
Dinoprost Tromethamine—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000502	0.00403	CcSEcCtD
Dinoprost Tromethamine—Hypersensitivity—Simvastatin—atherosclerosis	0.0005	0.00401	CcSEcCtD
Dinoprost Tromethamine—Diarrhoea—Lovastatin—atherosclerosis	0.000497	0.00399	CcSEcCtD
Dinoprost Tromethamine—Abdominal pain—Niacin—atherosclerosis	0.000493	0.00396	CcSEcCtD
Dinoprost Tromethamine—Body temperature increased—Niacin—atherosclerosis	0.000493	0.00396	CcSEcCtD
Dinoprost Tromethamine—Asthenia—Simvastatin—atherosclerosis	0.000487	0.00391	CcSEcCtD
Dinoprost Tromethamine—Diarrhoea—Ezetimibe—atherosclerosis	0.000487	0.00391	CcSEcCtD
Dinoprost Tromethamine—Abdominal pain—Pravastatin—atherosclerosis	0.000485	0.00389	CcSEcCtD
Dinoprost Tromethamine—Body temperature increased—Pravastatin—atherosclerosis	0.000485	0.00389	CcSEcCtD
Dinoprost Tromethamine—Pruritus—Simvastatin—atherosclerosis	0.000481	0.00386	CcSEcCtD
Dinoprost Tromethamine—Dizziness—Lovastatin—atherosclerosis	0.00048	0.00385	CcSEcCtD
Dinoprost Tromethamine—Dizziness—Ezetimibe—atherosclerosis	0.000471	0.00378	CcSEcCtD
Dinoprost Tromethamine—Diarrhoea—Simvastatin—atherosclerosis	0.000465	0.00373	CcSEcCtD
Dinoprost Tromethamine—Vomiting—Lovastatin—atherosclerosis	0.000462	0.0037	CcSEcCtD
Dinoprost Tromethamine—Hypersensitivity—Niacin—atherosclerosis	0.00046	0.00369	CcSEcCtD
Dinoprost Tromethamine—Rash—Lovastatin—atherosclerosis	0.000458	0.00367	CcSEcCtD
Dinoprost Tromethamine—Dermatitis—Lovastatin—atherosclerosis	0.000457	0.00367	CcSEcCtD
Dinoprost Tromethamine—Headache—Lovastatin—atherosclerosis	0.000455	0.00365	CcSEcCtD
Dinoprost Tromethamine—Vomiting—Ezetimibe—atherosclerosis	0.000453	0.00363	CcSEcCtD
Dinoprost Tromethamine—Hypersensitivity—Pravastatin—atherosclerosis	0.000452	0.00363	CcSEcCtD
Dinoprost Tromethamine—Dizziness—Simvastatin—atherosclerosis	0.000449	0.0036	CcSEcCtD
Dinoprost Tromethamine—Rash—Ezetimibe—atherosclerosis	0.000449	0.0036	CcSEcCtD
Dinoprost Tromethamine—Dermatitis—Ezetimibe—atherosclerosis	0.000449	0.0036	CcSEcCtD
Dinoprost Tromethamine—Asthenia—Niacin—atherosclerosis	0.000447	0.00359	CcSEcCtD
Dinoprost Tromethamine—Headache—Ezetimibe—atherosclerosis	0.000446	0.00358	CcSEcCtD
Dinoprost Tromethamine—Pruritus—Niacin—atherosclerosis	0.000441	0.00354	CcSEcCtD
Dinoprost Tromethamine—Asthenia—Pravastatin—atherosclerosis	0.000441	0.00353	CcSEcCtD
Dinoprost Tromethamine—Pruritus—Pravastatin—atherosclerosis	0.000434	0.00349	CcSEcCtD
Dinoprost Tromethamine—Vomiting—Simvastatin—atherosclerosis	0.000432	0.00346	CcSEcCtD
Dinoprost Tromethamine—Nausea—Lovastatin—atherosclerosis	0.000431	0.00346	CcSEcCtD
Dinoprost Tromethamine—Rash—Simvastatin—atherosclerosis	0.000428	0.00344	CcSEcCtD
Dinoprost Tromethamine—Dermatitis—Simvastatin—atherosclerosis	0.000428	0.00343	CcSEcCtD
Dinoprost Tromethamine—Diarrhoea—Niacin—atherosclerosis	0.000427	0.00342	CcSEcCtD
Dinoprost Tromethamine—Headache—Simvastatin—atherosclerosis	0.000426	0.00341	CcSEcCtD
Dinoprost Tromethamine—Nausea—Ezetimibe—atherosclerosis	0.000423	0.00339	CcSEcCtD
Dinoprost Tromethamine—Diarrhoea—Pravastatin—atherosclerosis	0.00042	0.00337	CcSEcCtD
Dinoprost Tromethamine—Dizziness—Niacin—atherosclerosis	0.000412	0.00331	CcSEcCtD
Dinoprost Tromethamine—Dizziness—Pravastatin—atherosclerosis	0.000406	0.00326	CcSEcCtD
Dinoprost Tromethamine—Nausea—Simvastatin—atherosclerosis	0.000403	0.00324	CcSEcCtD
Dinoprost Tromethamine—Vomiting—Niacin—atherosclerosis	0.000397	0.00318	CcSEcCtD
Dinoprost Tromethamine—Rash—Niacin—atherosclerosis	0.000393	0.00315	CcSEcCtD
Dinoprost Tromethamine—Dermatitis—Niacin—atherosclerosis	0.000393	0.00315	CcSEcCtD
Dinoprost Tromethamine—Headache—Niacin—atherosclerosis	0.000391	0.00313	CcSEcCtD
Dinoprost Tromethamine—Vomiting—Pravastatin—atherosclerosis	0.00039	0.00313	CcSEcCtD
Dinoprost Tromethamine—Rash—Pravastatin—atherosclerosis	0.000387	0.00311	CcSEcCtD
Dinoprost Tromethamine—Dermatitis—Pravastatin—atherosclerosis	0.000387	0.0031	CcSEcCtD
Dinoprost Tromethamine—Headache—Pravastatin—atherosclerosis	0.000385	0.00309	CcSEcCtD
Dinoprost Tromethamine—Nausea—Niacin—atherosclerosis	0.00037	0.00297	CcSEcCtD
Dinoprost Tromethamine—Nausea—Pravastatin—atherosclerosis	0.000365	0.00293	CcSEcCtD
Dinoprost Tromethamine—Tafluprost—PTGS2—atherosclerosis	0.000209	1	CrCbGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—LEP—atherosclerosis	3.11e-05	0.000151	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Hemostasis—MAPK3—atherosclerosis	3.09e-05	0.00015	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—CAV1—atherosclerosis	3.08e-05	0.000149	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—APOA1—atherosclerosis	3.07e-05	0.000149	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—KNG1—atherosclerosis	3.06e-05	0.000148	CbGpPWpGaD
Dinoprost Tromethamine—HPGDS—Metabolism—NOS3—atherosclerosis	3.06e-05	0.000148	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—AGTR1—atherosclerosis	3.04e-05	0.000148	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A7—Transmembrane transport of small molecules—ALB—atherosclerosis	3.04e-05	0.000147	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—NOS3—atherosclerosis	3e-05	0.000146	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Hemostasis—TGFB1—atherosclerosis	3e-05	0.000146	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—KNG1—atherosclerosis	3e-05	0.000145	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—KNG1—atherosclerosis	3e-05	0.000145	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling by GPCR—CCL2—atherosclerosis	2.98e-05	0.000145	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—AGTR1—atherosclerosis	2.98e-05	0.000144	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—AGTR1—atherosclerosis	2.98e-05	0.000144	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—ESR1—atherosclerosis	2.97e-05	0.000144	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—PLG—atherosclerosis	2.96e-05	0.000144	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Transmembrane transport of small molecules—HMOX1—atherosclerosis	2.96e-05	0.000143	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—PDGFB—atherosclerosis	2.93e-05	0.000142	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—F2—atherosclerosis	2.93e-05	0.000142	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling by GPCR—CCL2—atherosclerosis	2.92e-05	0.000142	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling by GPCR—CCL2—atherosclerosis	2.92e-05	0.000142	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—PLG—atherosclerosis	2.9e-05	0.000141	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—PLG—atherosclerosis	2.9e-05	0.000141	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—CYP27A1—atherosclerosis	2.89e-05	0.00014	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A6—Transmembrane transport of small molecules—PPARA—atherosclerosis	2.87e-05	0.000139	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—AGT—atherosclerosis	2.86e-05	0.000139	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Transmembrane transport of small molecules—APOB—atherosclerosis	2.83e-05	0.000137	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—SOCS3—atherosclerosis	2.81e-05	0.000136	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—PIK3CG—atherosclerosis	2.81e-05	0.000136	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—APOE—atherosclerosis	2.8e-05	0.000136	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—LEP—atherosclerosis	2.8e-05	0.000136	CbGpPWpGaD
Dinoprost Tromethamine—HPGDS—Metabolism—PTGS2—atherosclerosis	2.79e-05	0.000136	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—CAV1—atherosclerosis	2.78e-05	0.000135	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—APOA1—atherosclerosis	2.77e-05	0.000135	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—SOCS3—atherosclerosis	2.75e-05	0.000133	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—SOCS3—atherosclerosis	2.75e-05	0.000133	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—PLA2G2A—atherosclerosis	2.74e-05	0.000133	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—ALOX15—atherosclerosis	2.74e-05	0.000133	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—ALOX5AP—atherosclerosis	2.74e-05	0.000133	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—APOA2—atherosclerosis	2.74e-05	0.000133	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—MMP3—atherosclerosis	2.71e-05	0.000132	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—ABCG5—atherosclerosis	2.71e-05	0.000131	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—IGF2—atherosclerosis	2.7e-05	0.000131	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A6—Transmembrane transport of small molecules—APOA1—atherosclerosis	2.69e-05	0.00013	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling by GPCR—MAPK3—atherosclerosis	2.69e-05	0.00013	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—ESR1—atherosclerosis	2.68e-05	0.00013	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—CXCL8—atherosclerosis	2.67e-05	0.000129	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—INS—atherosclerosis	2.66e-05	0.000129	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—MMP3—atherosclerosis	2.65e-05	0.000129	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—MMP3—atherosclerosis	2.65e-05	0.000129	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—F2—atherosclerosis	2.65e-05	0.000128	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—IGF2—atherosclerosis	2.64e-05	0.000128	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—IGF2—atherosclerosis	2.64e-05	0.000128	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—APOB—atherosclerosis	2.62e-05	0.000127	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—CCL2—atherosclerosis	2.61e-05	0.000127	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—LPA—atherosclerosis	2.61e-05	0.000127	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—GPCR downstream signaling—CXCL8—atherosclerosis	2.6e-05	0.000126	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—EDN1—atherosclerosis	2.58e-05	0.000125	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—GPCR downstream signaling—AKT1—atherosclerosis	2.57e-05	0.000125	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—IGF1—atherosclerosis	2.57e-05	0.000125	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—APOB—atherosclerosis	2.57e-05	0.000124	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—APOB—atherosclerosis	2.57e-05	0.000124	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—CCL5—atherosclerosis	2.56e-05	0.000124	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A8—Transmembrane transport of small molecules—ALB—atherosclerosis	2.55e-05	0.000124	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—GPCR downstream signaling—CXCL8—atherosclerosis	2.54e-05	0.000123	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—GPCR downstream signaling—CXCL8—atherosclerosis	2.54e-05	0.000123	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling by GPCR—IL6—atherosclerosis	2.53e-05	0.000123	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—PIK3CG—atherosclerosis	2.53e-05	0.000123	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—BGN—atherosclerosis	2.53e-05	0.000123	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—EDN1—atherosclerosis	2.52e-05	0.000122	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—EDN1—atherosclerosis	2.52e-05	0.000122	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—APOA5—atherosclerosis	2.51e-05	0.000122	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—CCL5—atherosclerosis	2.5e-05	0.000122	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—CCL5—atherosclerosis	2.5e-05	0.000122	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—LPL—atherosclerosis	2.5e-05	0.000121	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—LPL—atherosclerosis	2.45e-05	0.000119	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—LPL—atherosclerosis	2.45e-05	0.000119	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—SERPINE1—atherosclerosis	2.44e-05	0.000118	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—PRKCG—atherosclerosis	2.43e-05	0.000118	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling by GPCR—MAPK3—atherosclerosis	2.42e-05	0.000118	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—PLA2G1B—atherosclerosis	2.41e-05	0.000117	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—MMP9—atherosclerosis	2.41e-05	0.000117	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—INS—atherosclerosis	2.4e-05	0.000116	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Transmembrane transport of small molecules—PPARA—atherosclerosis	2.39e-05	0.000116	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—NFKB1—atherosclerosis	2.38e-05	0.000116	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—PRKCG—atherosclerosis	2.38e-05	0.000116	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—PRKCG—atherosclerosis	2.38e-05	0.000116	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—SPP1—atherosclerosis	2.37e-05	0.000115	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling by GPCR—CXCL8—atherosclerosis	2.36e-05	0.000114	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—CCL2—atherosclerosis	2.36e-05	0.000114	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—MAPK8—atherosclerosis	2.34e-05	0.000114	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling by GPCR—AKT1—atherosclerosis	2.34e-05	0.000113	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—NOS3—atherosclerosis	2.33e-05	0.000113	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—ALOX5—atherosclerosis	2.33e-05	0.000113	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—SPP1—atherosclerosis	2.32e-05	0.000113	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—SPP1—atherosclerosis	2.32e-05	0.000113	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—IGF1—atherosclerosis	2.32e-05	0.000112	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling by GPCR—CXCL8—atherosclerosis	2.31e-05	0.000112	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling by GPCR—CXCL8—atherosclerosis	2.31e-05	0.000112	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Transmembrane transport of small molecules—APOA1—atherosclerosis	2.24e-05	0.000109	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—SERPINE1—atherosclerosis	2.2e-05	0.000107	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—PDGFB—atherosclerosis	2.19e-05	0.000106	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—VEGFA—atherosclerosis	2.16e-05	0.000105	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—PDGFB—atherosclerosis	2.15e-05	0.000104	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—PDGFB—atherosclerosis	2.15e-05	0.000104	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—STAT3—atherosclerosis	2.14e-05	0.000104	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—AGT—atherosclerosis	2.14e-05	0.000104	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A6—Transmembrane transport of small molecules—ALB—atherosclerosis	2.13e-05	0.000103	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—NOS3—atherosclerosis	2.1e-05	0.000102	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—APOE—atherosclerosis	2.1e-05	0.000102	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—LEP—atherosclerosis	2.1e-05	0.000102	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—AGT—atherosclerosis	2.1e-05	0.000102	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—AGT—atherosclerosis	2.1e-05	0.000102	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—NAMPT—atherosclerosis	2.09e-05	0.000101	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Hemostasis—AKT1—atherosclerosis	2.09e-05	0.000101	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—CAV1—atherosclerosis	2.08e-05	0.000101	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—LIPC—atherosclerosis	2.08e-05	0.000101	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—APOA1—atherosclerosis	2.07e-05	0.000101	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—CXCL8—atherosclerosis	2.07e-05	0.0001	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—APOC3—atherosclerosis	2.06e-05	0.0001	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—LEP—atherosclerosis	2.05e-05	9.96e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—APOE—atherosclerosis	2.05e-05	9.96e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—LEP—atherosclerosis	2.05e-05	9.96e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—APOE—atherosclerosis	2.05e-05	9.96e-05	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—LDLR—atherosclerosis	2.05e-05	9.95e-05	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—MAPK3—atherosclerosis	2.05e-05	9.93e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—CAV1—atherosclerosis	2.03e-05	9.87e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—CAV1—atherosclerosis	2.03e-05	9.87e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—APOA1—atherosclerosis	2.03e-05	9.85e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—APOA1—atherosclerosis	2.03e-05	9.85e-05	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—CETP—atherosclerosis	2e-05	9.72e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—ESR1—atherosclerosis	2e-05	9.71e-05	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—GPCR downstream signaling—AKT1—atherosclerosis	2e-05	9.68e-05	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—TGFB1—atherosclerosis	1.99e-05	9.64e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—F2—atherosclerosis	1.98e-05	9.6e-05	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling by GPCR—IL6—atherosclerosis	1.97e-05	9.53e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—ESR1—atherosclerosis	1.96e-05	9.51e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—ESR1—atherosclerosis	1.96e-05	9.51e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—F2—atherosclerosis	1.94e-05	9.39e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—F2—atherosclerosis	1.94e-05	9.39e-05	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—SCARB1—atherosclerosis	1.92e-05	9.31e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—PIK3CG—atherosclerosis	1.89e-05	9.18e-05	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—MMP9—atherosclerosis	1.87e-05	9.07e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—CXCL8—atherosclerosis	1.86e-05	9.04e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—PIK3CG—atherosclerosis	1.85e-05	8.99e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—PIK3CG—atherosclerosis	1.85e-05	8.99e-05	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—NFKB1—atherosclerosis	1.85e-05	8.97e-05	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—MAPK8—atherosclerosis	1.82e-05	8.82e-05	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling by GPCR—AKT1—atherosclerosis	1.81e-05	8.79e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling by GPCR—MAPK3—atherosclerosis	1.81e-05	8.79e-05	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—HMGCR—atherosclerosis	1.81e-05	8.79e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—GPCR downstream signaling—AKT1—atherosclerosis	1.8e-05	8.74e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—INS—atherosclerosis	1.79e-05	8.69e-05	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Transmembrane transport of small molecules—ALB—atherosclerosis	1.78e-05	8.62e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling by GPCR—MAPK3—atherosclerosis	1.77e-05	8.61e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling by GPCR—MAPK3—atherosclerosis	1.77e-05	8.61e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling by GPCR—IL6—atherosclerosis	1.77e-05	8.6e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—CCL2—atherosclerosis	1.76e-05	8.55e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—INS—atherosclerosis	1.75e-05	8.51e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—INS—atherosclerosis	1.75e-05	8.51e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—IGF1—atherosclerosis	1.73e-05	8.41e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—CCL2—atherosclerosis	1.73e-05	8.37e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—CCL2—atherosclerosis	1.73e-05	8.37e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—IGF1—atherosclerosis	1.7e-05	8.23e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—IGF1—atherosclerosis	1.7e-05	8.23e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—MMP9—atherosclerosis	1.69e-05	8.18e-05	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—VEGFA—atherosclerosis	1.68e-05	8.14e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—NFKB1—atherosclerosis	1.67e-05	8.09e-05	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—STAT3—atherosclerosis	1.66e-05	8.06e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—SERPINE1—atherosclerosis	1.65e-05	7.98e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—MAPK8—atherosclerosis	1.64e-05	7.95e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling by GPCR—AKT1—atherosclerosis	1.64e-05	7.93e-05	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—ABCA1—atherosclerosis	1.61e-05	7.83e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—SERPINE1—atherosclerosis	1.61e-05	7.82e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—SERPINE1—atherosclerosis	1.61e-05	7.82e-05	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—MAPK3—atherosclerosis	1.59e-05	7.7e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—NOS3—atherosclerosis	1.57e-05	7.62e-05	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—TGFB1—atherosclerosis	1.54e-05	7.47e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—NOS3—atherosclerosis	1.54e-05	7.46e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—NOS3—atherosclerosis	1.54e-05	7.46e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—VEGFA—atherosclerosis	1.51e-05	7.34e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—STAT3—atherosclerosis	1.5e-05	7.27e-05	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—IL6—atherosclerosis	1.5e-05	7.26e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—MAPK3—atherosclerosis	1.43e-05	6.95e-05	CbGpPWpGaD
Dinoprost Tromethamine—HPGDS—Metabolism—AKT1—atherosclerosis	1.4e-05	6.81e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—CXCL8—atherosclerosis	1.39e-05	6.76e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—TGFB1—atherosclerosis	1.39e-05	6.74e-05	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—HMOX1—atherosclerosis	1.39e-05	6.72e-05	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—AKT1—atherosclerosis	1.38e-05	6.7e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—CXCL8—atherosclerosis	1.36e-05	6.62e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—CXCL8—atherosclerosis	1.36e-05	6.62e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—GPCR downstream signaling—AKT1—atherosclerosis	1.35e-05	6.53e-05	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—APOB—atherosclerosis	1.33e-05	6.44e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling by GPCR—IL6—atherosclerosis	1.33e-05	6.43e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—GPCR downstream signaling—AKT1—atherosclerosis	1.32e-05	6.39e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—GPCR downstream signaling—AKT1—atherosclerosis	1.32e-05	6.39e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling by GPCR—IL6—atherosclerosis	1.3e-05	6.29e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling by GPCR—IL6—atherosclerosis	1.3e-05	6.29e-05	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—GSTM1—atherosclerosis	1.29e-05	6.26e-05	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—LPL—atherosclerosis	1.27e-05	6.15e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—MMP9—atherosclerosis	1.26e-05	6.12e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—NFKB1—atherosclerosis	1.25e-05	6.05e-05	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—GPX1—atherosclerosis	1.24e-05	6e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—MMP9—atherosclerosis	1.23e-05	5.99e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—MMP9—atherosclerosis	1.23e-05	5.99e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—MAPK8—atherosclerosis	1.23e-05	5.95e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling by GPCR—AKT1—atherosclerosis	1.22e-05	5.93e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—NFKB1—atherosclerosis	1.22e-05	5.92e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—NFKB1—atherosclerosis	1.22e-05	5.92e-05	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—CD36—atherosclerosis	1.2e-05	5.84e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—MAPK8—atherosclerosis	1.2e-05	5.82e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—MAPK8—atherosclerosis	1.2e-05	5.82e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling by GPCR—AKT1—atherosclerosis	1.2e-05	5.81e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling by GPCR—AKT1—atherosclerosis	1.2e-05	5.81e-05	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—IL6—atherosclerosis	1.16e-05	5.63e-05	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—MTHFR—atherosclerosis	1.14e-05	5.53e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—VEGFA—atherosclerosis	1.13e-05	5.49e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—STAT3—atherosclerosis	1.12e-05	5.44e-05	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—PPARA—atherosclerosis	1.12e-05	5.43e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—VEGFA—atherosclerosis	1.11e-05	5.38e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—VEGFA—atherosclerosis	1.11e-05	5.38e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—STAT3—atherosclerosis	1.1e-05	5.32e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—STAT3—atherosclerosis	1.1e-05	5.32e-05	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—AGT—atherosclerosis	1.08e-05	5.26e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—MAPK3—atherosclerosis	1.07e-05	5.2e-05	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—AKT1—atherosclerosis	1.07e-05	5.2e-05	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—APOE—atherosclerosis	1.06e-05	5.15e-05	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—CAV1—atherosclerosis	1.05e-05	5.11e-05	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—APOA1—atherosclerosis	1.05e-05	5.09e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—MAPK3—atherosclerosis	1.05e-05	5.09e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—MAPK3—atherosclerosis	1.05e-05	5.09e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—IL6—atherosclerosis	1.05e-05	5.08e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—TGFB1—atherosclerosis	1.04e-05	5.04e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—TGFB1—atherosclerosis	1.02e-05	4.93e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—TGFB1—atherosclerosis	1.02e-05	4.93e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—AKT1—atherosclerosis	9.66e-06	4.69e-05	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—PIK3CG—atherosclerosis	9.59e-06	4.65e-05	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—PPARG—atherosclerosis	9.25e-06	4.49e-05	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—INS—atherosclerosis	9.07e-06	4.4e-05	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—ALB—atherosclerosis	8.32e-06	4.04e-05	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—NOS3—atherosclerosis	7.96e-06	3.86e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—IL6—atherosclerosis	7.83e-06	3.8e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—IL6—atherosclerosis	7.66e-06	3.72e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—IL6—atherosclerosis	7.66e-06	3.72e-05	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—PTGS2—atherosclerosis	7.28e-06	3.53e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—AKT1—atherosclerosis	7.22e-06	3.5e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—AKT1—atherosclerosis	7.07e-06	3.43e-05	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—AKT1—atherosclerosis	7.07e-06	3.43e-05	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—AKT1—atherosclerosis	3.66e-06	1.77e-05	CbGpPWpGaD
